#United States #Austin #Texas #Ottobock #HB 426

Texas Expands Access to Infant Orthoses

In a groundbreaking move, Texas has passed HB 426, a significant piece of legislation that aims to improve access to cranial remolding orthoses (CROs) for infants covered by Medicaid. This bill, signed into law recently, is a major triumph for Texas families grappling with conditions like plagiocephaly and craniosynostosis—deformities that, if not treated, can lead to lasting developmental issues.

Previously, many families in Texas encountered substantial financial obstacles and delays in securing these crucial medical devices due to a lack of consistent coverage and ambiguous eligibility requirements. With the enactment of HB 426, this troubling scenario stands to change. It is set to take effect on September 1, 2025, marking a significant milestone in pediatric orthotic care.

Two prominent companies in the field of orthotics and prosthetics, Ottobock and Hanger, Inc., based in Austin, were instrumental in championing this important legislation. They eagerly participated in advocacy efforts, raising awareness about the need for improved access to these essential devices, and engaged in discussions with legislators to push for this change. Together with a coalition of parents, clinicians, and advocates, they organized a Capitol Day event earlier this year, which united voices calling for legislative action.

Katie Toth, a certified orthotist and the Director of Education and Research at Surestep—an entity under Hanger—remarked, “For parents across Texas, HB 426 removes unnecessary obstacles and ensures their children can receive the care they need.” She emphasizes that the focus within pediatric orthotic care is to help children achieve their fullest potential.

Russ Lundstrom, who leads Clinical Research and Services at Ottobock, added, “This victory is not just for our industry; it’s for all parents in Texas who are navigating the challenges associated with uncertain diagnoses.” He expressed gratitude to lawmakers for acknowledging the critical impact early intervention and access to orthotic care have on child development.

Notably, with the passage of HB 426, Texas now joins a growing number of states that have recognized the necessity of establishing clinical eligibility criteria for CROs, aligning with best practices and expert recommendations. These legislative changes not only enhance access to essential medical care but also work toward reducing disparities for many families—ultimately improving the health outcomes for thousands of infants each year.

Both Ottobock and Hanger, Inc. continue to advocate for policies that support individuals grappling with limb loss, limb differences, and other physical challenges throughout their lives, from infancy to adulthood. Their unwavering commitment underscores the importance of accessible orthotic intervention in fostering human potential.

Hanger, Inc., a leading provider in the orthotic and prosthetic sector, operates over 925 clinics across the country, providing a range of services and solutions tailored to meet diverse patient needs. On the other hand, Ottobock has been a pioneering force in the bionics industry for over a century, developing state-of-the-art prosthetics and mobility solutions aimed at promoting independence and enhancing the quality of life for people with reduced mobility.

As this historic legislation takes effect, its impact will likely reverberate through the lives of many families in Texas, instilling hope and opening doors to better healthcare access for infants who require specialized support for their head shape development.